HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.

AbstractBACKGROUND:
We previously found that enhanced expression of hepatocyte nuclear factor 4α (HNF-4α) is associated with hyper-proliferation of colon carcinoma cells. Here, the effect of histone deacetylase (HDAC) inhibitors on proliferation and the expression of HNF-4α and its downstream target genes were assessed in HM7, LS174T, HT29 and Caco-2 colon carcinoma cell lines.
RESULTS:
HNF-4α expression was found to vary in the different colon carcinoma cell lines tested, being highest in HM7. Additionally, a direct correlation with proliferation was observed. In HM7 cells, the weak HDAC inhibitor butyrate significantly inhibited the transcription of HNF-4α, its downstream target gene MUC4, and genes associated with proliferation, including the proliferating cell nuclear antigen gene PCNA. siRNA-mediated silencing of HNF-4α exerted an effect similar to butyrate on HM7 cell proliferation. The stronger HDAC inhibitor trichostatin A (TSA) exerted an effect similar to that of siRNA-mediated HNF-4α silencing and, concomitantly, inhibited the expression of the transcription factor gene SP1. Also, siRNA-mediated silencing of HDAC3 and HDAC4 reduced HNF-4α expression. Chromatin immunoprecipitation (ChIP) assays revealed that TSA induces hyperacetylation of histones H3 and H4 and, concomitantly, inhibits SP1 binding to the HNF-4α promoter. Subsequent electromobility shift assays supported these latter findings.
CONCLUSIONS:
HNF-4α transcriptional expression and activity are tightly controlled by epigenetic mechanisms. HDAC inhibitor targeting of HNF-4α may serve as an effective treatment for advanced colon carcinomas, since downstream cancer-associated target genes such as MUC4 are significantly down-regulated by this treatment.
AuthorsAnna Algamas-Dimantov, Einav Yehuda-Shnaidman, Irena Peri, Betty Schwartz
JournalCellular oncology (Dordrecht) (Cell Oncol (Dordr)) Vol. 36 Issue 2 Pg. 155-67 (Apr 2013) ISSN: 2211-3436 [Electronic] Netherlands
PMID23307400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Butyrates
  • HNF4A protein, human
  • Hepatocyte Nuclear Factor 4
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • MUC4 protein, human
  • Mucin-4
  • Repressor Proteins
  • Sp1 Transcription Factor
  • trichostatin A
  • HDAC4 protein, human
  • Histone Deacetylases
  • histone deacetylase 3
Topics
  • Acetylation (drug effects)
  • Blotting, Western
  • Butyrates (pharmacology)
  • Caco-2 Cells
  • Cell Line, Tumor
  • Cell Proliferation
  • Colonic Neoplasms (genetics, metabolism, pathology)
  • Epigenesis, Genetic
  • Gene Expression Regulation, Neoplastic
  • HT29 Cells
  • Hepatocyte Nuclear Factor 4 (genetics, metabolism)
  • Histone Deacetylase Inhibitors (pharmacology)
  • Histone Deacetylases (genetics, metabolism)
  • Histones (metabolism)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Mucin-4 (genetics, metabolism)
  • Promoter Regions, Genetic (genetics)
  • Protein Binding (drug effects)
  • RNA Interference
  • Repressor Proteins (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sp1 Transcription Factor (genetics, metabolism)
  • Transcription, Genetic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: